Polyphenols in Metabolic Diseases

Molecules. 2022 Sep 23;27(19):6280. doi: 10.3390/molecules27196280.

Abstract

Polyphenols (PPs) are a large group of phytochemicals containing phenolic rings with two or more hydroxyl groups. They possess powerful antioxidant properties, multiple therapeutic effects, and possible health benefits in vivo and in vitro, as well as reported clinical studies. Considering their free-radical scavenging and anti-inflammatory properties, these substances can be used to treat different kinds of conditions associated with metabolic disorders. Many symptoms of metabolic syndrome (MtS), including obesity, dyslipidemia, atherosclerosis, elevated blood sugar, accelerating aging, liver intoxication, hypertension, as well as cancer and neurodegenerative disorders, are substantially relieved by dietary PPs. The present study explores the bioprotective properties and associated underlying mechanisms of PPs. A detailed understanding of these natural compounds will open up new opportunities for producing unique natural PP-rich dietary and medicinal plans, ultimately affirming their health benefits.

Keywords: bioprotective property; metabolic syndrome; natural sources; phenolic compounds; therapeutic effect.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Blood Glucose
  • Humans
  • Metabolic Syndrome* / drug therapy
  • Polyphenols* / chemistry
  • Polyphenols* / pharmacology
  • Polyphenols* / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Blood Glucose
  • Polyphenols

Grants and funding

This research received no external funding.